Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Taxes × 90 days × Clear all

Phase

Phase 2 31 Phase 3 24 Phase 1 13 Phase 1/2 8 Phase 2/3 4 Phase NA 2 Phase EARLY_PHASE1 1 Phase 4 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Non-Small Cell Lung Cancer Metastatic 1

Interventions

Specimen Handling 5 Dexamethasone 5 Rituximab 4 Prednisone 4 Cisplatin 4 Carboplatin 4 darolutamide 3 Vincristine 3 Tobacco Use Cessation Devices 3 Magnetic Resonance Spectroscopy 3 Letrozole 3 Injections 3 Hydromorphone 3 Bevacizumab 3 trametinib 2 ribociclib 2 pirtobrutinib 2 pembrolizumab 2 obinutuzumab 2 gadolinium ethoxybenzyl DTPA 2 enzalutamide 2 enfortumab vedotin 2 dabrafenib 2 Watchful Waiting 2 Thalidomide 2 Standard of Care 2 Propofol 2 Paclitaxel 2 Oxaliplatin 2 Observation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05689671 2026-03-10

ANTELOPE

Charite University, Berlin, Germany

Phase 4 Active not recruiting

Non-Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡